The FINANCIAL — Bayer is making drugs with a market value of just under EUR 1.5 million available free of charge to aid organizations and authorities in Turkey, Greece and Austria to treat refugees.
The biggest share of the donation, which includes ointments, pain relievers and antibiotics, is to go to Turkey, according to Bayer.
“We are delighted to be able to help with these specifically needed drugs,” said Michael König, member of the Bayer Board of Management responsible for Human Resources, Technology and Innovation.
Bayer is also already implementing several programs for the integration of refugees. These include a pilot project with the Berlin Senate to introduce scientific study materials for refugee children with no knowledge of German and a foundation course providing language training and career guidance to young people.
Discussion about this post